Early Detection of Skin Cancer With Sensor Technology

Status Completed

Clinical Trial Summary

Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02668614
Study type	Interventional
Source	Lawson Health Research Institute
Contact
Status	Completed
Phase	N/A
Start date	February 2016
Completion date	February 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00875381` - Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin	N/A
Recruiting	`NCT04362722` - Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients	Phase 2
Completed	`NCT00218829` - DMSO-PDT of BCC - A 6 Year Follow up	N/A
Completed	`NCT02674009` - Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)
Recruiting	`NCT05970497` - A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors	Phase 1
Terminated	`NCT02956889` - To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma	Phase 2
Completed	`NCT01204073` - A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies	Phase 1
Completed	`NCT02029352` - Topical Green Tea Ointment in Treatment of Superficial Skin Cancer	Phase 2/Phase 3
Completed	`NCT03569345` - Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate	Phase 1/Phase 2
Recruiting	`NCT05463757` - Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Completed	`NCT00189280` - Aldara for the Treatment of Large and/or Multiple sBCC	Phase 3
Completed	`NCT03541252` - Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study	Phase 1/Phase 2
Recruiting	`NCT05133427` - HIFU for Treatment of Non-nodular and Recurrent BCC	N/A
Active, not recruiting	`NCT02367547` - Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL	Phase 1/Phase 2
Completed	`NCT00007631` - Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer	Phase 3
Active, not recruiting	`NCT05138328` - Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance	N/A
Completed	`NCT03132636` - PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy	Phase 2
Completed	`NCT00847912` - CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial	Phase 4
Enrolling by invitation	`NCT02666833` - Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers	N/A
Completed	`NCT01482104` - New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)	N/A